Home |Research|Staff

Staff

Prof. Dr. Gerhard Gründer

Department Head

Department Molecular Neuroimaging

Phone: +49 621 1703-1900

Fax: +49 621 1703-80-1900

e-mail

Main Medical Building, Groundfloor, Room 056
 

Secretariat

Andrea Trautner
Phone: 0621 1703-1901
e-mail
 

Assistant, Secretariat Department of Molecular Neuroimaging

Main Medical Building, Groundfloor, Room 037

Publications in peer reviewed journals since 2006

TOP 5 publications:

  1. Gründer G, Mertens L. Psilocybin for Depression.N Engl J Med. 2021 385(9):863.
  2. Feifel D, Seynaeve M, Cubala WJ, Dunbar F, Gründer G, Dueñas Herrero RM, Hindocha C, Liknaitzky P, McGuigan SM, Mehta S, Pierce M, Repantis D, Roberts C, Wiegand F, Conley R. Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial.JAMA. 2026 Oct 26. [Epub ahead of print].
  3. Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Verde PE, Correll CU, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl TB, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Leucht S, Cordes J, COMBINE Study Group . Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial.Lancet Psychiatry. 2022 9(4):291-306.
  4. Gründer G, Brand M, Mertens L, Jungaberle H, Kärtner L, Scharf DJ, Spangemacher M, Wolff M. Treatment with psychedelics is psychotherapy: beyond reductionism.Lancet Psychiatry. 2024 11(3):231-236. Epub 2023 Dec 12.
  5. Gründer G, Mertens L, Jungaberle A, Jungaberle H, Spangemacher M. Compassionate use of psilocybin for treatment-resistant depression in Germany.Lancet Psychiatry. 2026 13(2):91-93. Epub 2025 Sep 18.

Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de